Back to search
FDAFDA · Food and drugs·Recall number D-0170-2017

Qnasl (beclomethasone dipropionate) Nasal Aerosol 40 Mcg, 60 Metered Sprays, Rx only, Manufactured for Teva Respiratory, LLC, Horsham, PA 19044, By: 3M Drug Delivery Systems, Northridge, CA 91324, NDC 59310-206-06 and 59310-206-08 (Physician Samples).

Published December 14, 2016 · Recall initiated: November 1, 2016

Summary

FDA records drug Class III recall D-0170-2017, published December 14, 2016 and initiated November 1, 2016. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 201, 234 Canisters; Lot: Lot #: 150096, Exp. 3/2017; Lot #: 150327, Exp. 10/2017. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Content Uniformity: Product was out of specification for spray content uniformity obtained during stability testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teva Pharmaceuticals USA
Distributor
Nationwide
Lot
Lot #: 150096, Exp. 3/2017; Lot #: 150327, Exp. 10/2017
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Qnasl (beclomethasone dipropionate) Nasal Aerosol 40 Mcg, 60 Metered Sprays, Rx only, Manufactured for Teva Respiratory, LLC, Horsham, PA 19044, By: 3M Drug Delivery Systems, Northridge, CA 91324, NDC 59310-206-06 and 59310-206-08 (Physician Samples). recalled?

Yes. FDA published recall D-0170-2017 on December 14, 2016. Reported hazard: Failed Content Uniformity: Product was out of specification for spray content uniformity obtained during stability testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter